TFF Pharmaceuticals, Inc.

VANGUARD GROUP INC

Report date

9/30/2023

Quarter

2023 Q3

Filed

12/18/2023

Shares

846,884

Value ($000)

296

Weight

0.0%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	12/18/2023	296	0.0%	846,884	9/30/2023
2023 Q2	8/14/2023	401	0.0%	853,663	6/30/2023
2023 Q1	7/14/2023	589	0.0%	859,449	3/31/2023
2022 Q4	2/10/2023	902	0.0%	859,449	12/31/2022
2022 Q3	11/14/2022	3,526	0.0%	868,431	9/30/2022
2022 Q2	8/12/2022	4,907	0.0%	868,431	6/30/2022
2022 Q1	5/13/2022	5,458	0.0%	864,983	3/31/2022
2021 Q4	2/14/2022	7,203	0.0%	812,170	12/31/2021
2021 Q3	11/12/2021	6,138	0.0%	795,038	9/30/2021
2021 Q2	8/13/2021	7,417	0.0%	771,854	6/30/2021
2021 Q1	5/14/2021	9,457	0.0%	696,907	3/31/2021
2020 Q4	2/12/2021	8,975	0.0%	626,770	12/31/2020
2020 Q3	11/16/2020	6,086	0.0%	329,531	9/30/2020
2020 Q2	8/14/2020	366	0.0%	63,584	6/30/2020
2020 Q1	5/15/2020	244	0.0%	63,584	3/31/2020
2019 Q4	2/14/2020	278	0.0%	52,031	12/31/2019